Market Tracker

03/27 6:01pm ET

Isis Pharmaceuticals Inc (NASDAQ:ISIS)

63.37
Delayed Data
As of Mar 27
 +2.22 / +3.63%
Today’s Change
22.25
Today|||52-Week Range
77.80
+2.64%
Year-to-Date

Today’s Trading

Previous close61.15
Today’s open61.57
Day’s range61.41 - 64.44
Volume4,336,080
Average volume (3 months)3,298,583
Market cap$7.3B
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+40.00%
Earnings growth (this year)-147.73%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+45.41%
P/E ratioNM
Price/Sales33.93
Price/Book28.10

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...+0.97+1.46%
ALNYAlnylam Pharmaceutic...+4.42+4.44%
ICLRICON PLC+0.85+1.22%
CRLCharles River Labora...+0.60+0.76%
Data as of 4:02pm ET, 03/27/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$214.2M
Annual profit (last year)-$39.0M
Net profit margin-18.20%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Stanley T. Crooke
Chief Operating Officer, Secretary &
Director
B. Lynne Parshall
Corporate headquarters
Carlsbad, California

Forecasts